{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:19:03Z","timestamp":1790522343813,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Due to the lack of prospective, randomized, controlled clinical studies on inflammation and cardiovascular involvement, the exact mechanism of cardiac injury among patients with Coronavirus Disease 2019 (COVID-19) still remains uncertain. It was demonstrated that there is a high and significantly positive linear correlation between troponin T and plasma high-sensitivity C-reactive protein levels, biomarkers of cardiac injury and systemic inflammation, respectively. Cardiac injury and inflammation is a relatively common association among patients hospitalized with COVID-19, and it is related to higher risk of in-hospital mortality. In our literature search, we identified several potential mechanisms of myocardial tissue damage, namely, coronavirus-associated acute myocarditis, angiotensin-converting enzyme 2 receptor binding affinity to the virus Spike protein, increased cytokine secretion, and hypoxia-induced cardiac myocyte apoptosis. Elucidation of the disease pathogenesis and prospective histopathological studies are crucial for future proper treatment in case of renewed outbreaks. Of interest is that with hundred of thousands of bodies available for autopsy studies, no prospective investigation has been reported so far. Strong efforts and continued research of the cardiovascular complications and identification of risk factors for poor prognosis in COVID-19 are steadily needed. The high morbidity and mortality of COVID-19, its monumental economic burden and social impact, the despair of a new pandemic outbreak, and the thread of potential utilization of novel severe acute respiratory syndrome coronavirus 2 as biologic weapons make it a preponderant necessity to better comprehend the therapeutic management of this lethal disease. Emerging as an acute infectious disease, COVID-19 may become a chronic epidemic because of genetic recombination. Therefore, we should be ready for the reemergence of COVID-19 or other coronaviruses.<\/jats:p>","DOI":"10.1097\/hpc.0000000000000227","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T19:54:47Z","timestamp":1591300487000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Potential Mechanisms of Cardiac Injury and Common Pathways of Inflammation in Patients With COVID-19"],"prefix":"10.1097","volume":"20","author":[{"given":"Osmar Antonio","family":"Centuri\u00f3n","sequence":"first","affiliation":[{"name":"Department of Health Sciences\u2019s Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay; and"},{"name":"Cardiology Department, First Department of Internal Medicine, Clinic Hospital, Asunci\u00f3n National University, San Lorenzo, Paraguay."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina E.","family":"Scavenius","sequence":"additional","affiliation":[{"name":"Department of Health Sciences\u2019s Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay; and"},{"name":"Cardiology Department, First Department of Internal Medicine, Clinic Hospital, Asunci\u00f3n National University, San Lorenzo, Paraguay."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Health Sciences\u2019s Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay; and"},{"name":"Cardiology Department, First Department of Internal Medicine, Clinic Hospital, Asunci\u00f3n National University, San Lorenzo, Paraguay."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Torales","sequence":"additional","affiliation":[{"name":"Department of Health Sciences\u2019s Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay; and"},{"name":"Cardiology Department, First Department of Internal Medicine, Clinic Hospital, Asunci\u00f3n National University, San Lorenzo, Paraguay."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds M.","family":"Mi\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Health Sciences\u2019s Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay; and"},{"name":"Cardiology Department, First Department of Internal Medicine, Clinic Hospital, Asunci\u00f3n National University, San Lorenzo, Paraguay."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"R3-20250506","first-page":"e200950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 inWuhan, China.","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R4-20250506","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention.","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R5-20250506","first-page":"e201017","article-title":"Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19).","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses.","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/resp.13196","article-title":"MERS, SARS and other coronaviruses as causes of pneumonia.","volume":"23","author":"Yin","year":"2018","journal-title":"Respirology"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight.","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome.","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad Med J"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus.","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann Saudi Med"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the perfusion conformation.","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection.","volume":"14","author":"Xin","year":"2020","journal-title":"Front Med"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure.","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC Working Group on coronary pathophysiology and microcirculation position paper on \u2018coronary microvascular dysfunction in cardiovascular disease\u2019.","volume":"116","author":"Padro","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","article-title":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.","volume":"108","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"R19-20250506","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2020.04.009","article-title":"Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms.","author":"Tersalvi","year":"2020","journal-title":"J Cardiac Fail"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"R21-20250506","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (Angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent.","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"issue":"Pt 1","key":"R23-20250506","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.","volume":"93","author":"Hamming","year":"2008","journal-title":"Exp Physiol"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10654-020-00628-1","article-title":"The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.","volume":"35","author":"Gonzalez-Jaramillo","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans.","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"R29-20250506","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.","volume":"296","author":"Soler","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R31-20250506","first-page":"419","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia.","volume":"31","author":"Henry","year":"2018","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R32-20250506","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R33-20250506","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"R34-20250506","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25809","article-title":"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.","author":"Han","year":"2020","journal-title":"J Med Virol"},{"key":"R35-20250506","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-020-01352-w","article-title":"Prognostic value of NT-proBNP in patients with severe COVID-19.","volume":"21","author":"Gao","year":"2020","journal-title":"Respir Res"},{"key":"R36-20250506","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","article-title":"COVID-19-related myocarditis in a 21-year-old female patient.","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"key":"R37-20250506","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection.","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"key":"R38-20250506","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19).","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R39-20250506","article-title":"Cardiac troponin in COVID-2019.","author":"Lippi","year":"2020","journal-title":"Progress Cardiovasc Dis"},{"key":"R40-20250506","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2020.04.003","article-title":"Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society.","author":"Sapp","year":"2020","journal-title":"Can J of Cardiol"},{"key":"R41-20250506","article-title":"Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: a scientific statement from the Indian Heart Rhythm Society.","author":"Kapoor","year":"2020","journal-title":"Ind Pac Electrophysiol J"},{"key":"R42-20250506","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19.","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R43-20250506","first-page":"4626279","article-title":"Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine.","volume":"2016","author":"O\u2019Laughlin","year":"2016","journal-title":"Case Rep Cardiol"},{"key":"R44-20250506","doi-asserted-by":"crossref","first-page":"2264.e5","DOI":"10.1016\/j.ajem.2019.158387","article-title":"Toxicokinetics of hydroxychloroquine following a massive overdose.","volume":"37","author":"de Olano","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R45-20250506","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death.","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"R46-20250506","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"R47-20250506","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019.","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"R48-20250506","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"R49-20250506","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/166.5.978","article-title":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection.","volume":"166","author":"Alexander","year":"1992","journal-title":"J Infect Dis"},{"key":"R50-20250506","article-title":"End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV.","author":"Dong","year":"2020","journal-title":"JACC: Heart Failure"},{"key":"R51-20250506","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.","author":"Cheng","year":"2020","journal-title":"J Med Virol"},{"key":"R52-20250506","doi-asserted-by":"crossref","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19).","author":"Bourgonje","year":"2020","journal-title":"J Pathol"},{"key":"R53-20250506","article-title":"A viewpoint on angiotensin-converting enzyme 2, anti-hypertensives and Coronavirus Disease 2019 (COVID-19).","author":"Mali","year":"2020","journal-title":"Infect Disord Drug Targets"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:03:25Z","timestamp":1746558205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000227","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,27]]}}}